Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores – A pooled analysis of RTOG 0129 and 0522
Musaddiq J. Awan,Haley Gittleman,Jill Barnholtz-Sloan,Mitchell Machtay,Phuc Felix Nguyen-Tan,David I. Rosenthal,Christopher Schultz,Bradley J. Huth,Wade L Thorstad,Steven J. Frank,Harold Kim,Robert L. Foote,Miriam N. Lango,George Shenouda,Mohan Suntharalingam,Jonathan Harris,Qiang Zhang,Quynh-Thu Le,Min Yao,on behalf of the NRG Oncology Group
DOI: https://doi.org/10.1016/j.oraloncology.2021.105241
IF: 5.972
2021-05-01
Oral Oncology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>To develop nomograms predicting overall survival (OS), freedom from locoregional recurrence (FFLR), and freedom from distant metastasis (FFDM) for patients receiving chemoradiation for laryngeal squamous cell carcinoma (LSCC).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Material and methods</h3><p>Clinical and treatment data for patients with LSCC enrolled on NRG Oncology/RTOG 0129 and 0522 were extracted from the RTOG database. The dataset was partitioned into 70% training and 30% independent validation datasets. Significant predictors of OS, FFLR, and FFDM were obtained using univariate analysis on the training dataset. Nomograms were built using multivariate analysis with four a priori variables (age, gender, T-stage, and N-stage) and significant predictors from the univariate analyses. These nomograms were internally and externally validated using c-statistics (c) on the training and validation datasets, respectively.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The OS nomogram included age, gender, T stage, N stage, and number of cisplatin cycles. The FFLR nomogram included age, gender, T-stage, N-stage, and time-equivalent biologically effective dose. The FFDM nomogram included age, gender, N-stage, and number of cisplatin cycles. Internal validation of the OS nomogram, FFLR nomogram, and FFDM nomogram yielded c = 0.66, c = 0.66 and c = 0.73, respectively. External validation of these nomograms yielded c = 0.59, c = 0.70, and c = 0.73, respectively. Using nomogram score cutoffs, three risk groups were separated for each outcome.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>We have developed and validated easy-to-use nomograms for LSCC outcomes using prospective cooperative group trial data.</p>
dentistry, oral surgery & medicine,oncology